Patient care activities by community pharmacists in a capitation funding model mental health and addictions program

Table 6 Medication issues and medication use at enrollment in the Bloom Program

	All patients (n = 201)		Patients with ≥1 follow-up visit (n = 182)
	n	%	n	%
Medication issues:
Treatment optimization	162	80.6	148	81.3
Adverse effects	49	24.4	44	24.2
Non-adherence	22	10.9	15	8.2
Medication withdrawal	27	13.4	23	12.6
Inappropriate polytherapy	12	6.0	9	4.9
Medications:
Antidepressants	145	72.1	130	71.4
Benzodiazepines-Z drugs	107	53.2	98	53.8
Antipsychotics	58	28.9	50	27.5
Mood stabilizers	21	10.4	19	10.4
Psychostimulants	12	6.0	12	6.6
Other Psychotropics	13	6.5	12	6.6
Opioids	24	11.9	23	12.6
Opioid replacement therapy	15	7.5	14	7.7
Multiple psychotropic medications	136	67.7	122	67
No psychotropic medications	9	4.5	7	3.8
≥ 1 physical health medications	142	70.6	130	71.4
	Mean	SD	Mean	SD
Number of current medications	5.4	4.0	5.5	4.1
Range of current medications	0 to 24		0 to 24

ISSN: 1471-244X